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Abstract
Background: Disparities in cervical cancer screening are known to exist in Ontario, Canada for foreign-born
women. The relative importance of various barriers to screening may vary across ethnic groups. This study aimed
to determine how predictors of low cervical cancer screening, reflective of sociodemographics, the health care
system, and migration, varied by region of origin for Ontario’s immigrant women.
Methods: Using a validated billing code algorithm, we determined the proportion of women who were not
screened during the three-year period of 2006-2008 among 455 864 identified immigrant women living in
Ontario’s urban centres. We created eight identical multivariate Poisson models, stratified by eight regions of origin
for immigrant women. In these models, we adjusted for various sociodemographic, health care-related and
migration-related variables. We then used the resulting adjusted relative risks to calculate population-attributable
fractions for each variable by region of origin.
Results: Region of origin was not a significant source of effect modification for lack of recent cervical cancer
screening. Certain variables were significantly associated with lack of screening across all or nearly all world regions.
These consisted of not being in the 35-49 year age group, residence in the lowest-income neighbourhoods, not
being in a primary care patient enrolment model, a provider from the same region, and not having a female
provider. For all women, the highest population-attributable risk was seen for not having a female provider, with
values ranging from 16.8% [95% CI 14.6-19.1%] among women from the Middle East and North Africa to 27.4%
[95% CI 26.2-28.6%] for women from East Asia and the Pacific.
Conclusions: To increase screening rates across immigrant groups, efforts should be made to ensure that women
have access to a regular source of primary care, and ideally access to a female health professional. Efforts should
also be made to increase the enrolment of immigrant women in new primary care patient enrolment models.
Background
Widespread screening using the Papanicolaou (Pap) test
has been proven to dramatically reduce cervical cancer
rates, and women who develop cervical cancer are most
often women who have not been appropriately screened
[1-5]. Therefore, in Ontario, Canada, evidence-based
guidelines recommend that screening occur at least
once every three years for all women with a history of
vaginal sexual activity until 70 years of age[5]. However,
the literature suggests that adherence to guidelines is
not complete or equitable in our setting. Disparities in
cervical cancer screening for foreign-born women have
long been documented in the Ontario and Canadian lit-
erature, using both self-report and administrative data
[6-13]. This risk of non-screening is not equal across
immigrant groups. In our previous work, although all
immigrant groups had significantly lower screening rates
than long-term residents of the province [53.1% vs.
64.6%), women from South Asia and from the Middle
East and North Africa were the most vulnerable to lack
of screening, and women from Western Europe and
from Latin America and the Caribbean were the least
vulnerable[14]. These findings were in the context of
screening rates and knowledge about the Pap test being
quite low in many South Asian and Middle Eastern
countries. [2,15,16].
The underlying mechanisms for screening disparities
for immigrant women may lie in sociodemographic
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any medium, provided the original work is properly cited.barriers, barriers rooted in the health care system, cul-
tural or migration-related barriers or, most likely,
some combination of the three [4,17-23]. As well, it is
feasible that the relative importance of these barriers
varies between ethnic groups. For example, the gender
of the physician performing the Pap test or language
barriers may be of more importance for women from
one cultural or language group than from another.
Therefore, the aims of this study were to: i) determine
if the independent effects on cervical cancer screening
of various factors reflective of sociodemographics, the
health care system, and culture and migration were
modified by region of origin for identified immigrant
women in Ontario, and ii) to calculate population-
attributable fractions for these factors for each region
of origin.
Methods
Study Setting
According to the 2006 Census, Ontario is Canada’sl a r -
gest province with a population of over 12 million peo-
ple, over 28% of whom are foreign-born[24]. More than
half of all Canada’s immigrants settle in Ontario[25].
Asia is currently the main source continent, and India
the number one source country, for newcomers to the
province[25]. Nearly 75% of the province’sp o p u l a t i o n
live in one of fifteen census metropolitan areas (CMAs)
i.e. a geographic area with a total population of at least
100 000, of which 50 000 or more live in an urban core
[26,27]. For Ontario’s foreign-born population, 94.0%
l i v ei naC M A [ 2 8 ] .T h e r e f o r e ,w el i m i t e dt h es t u d ys e t -
ting to Ontario’s CMAs. Ontario has a single, govern-
ment-run, universal health insurance plan that pays for
all medically necessary services, including cervical can-
cer screening.
Data Sources
Details on data sources have been previously published
elsewhere[14].
Study Cohort
Our cohort consisted of all women in Ontario who were
alive and eligible for health coverage from January 1,
2006 to December 31, 2008, who ranged in age from 18
to 69 years for the entire three-year study period, whose
most recent postal code was in a CMA, and who were
identified immigrants based on the Landed Immigrant
Data System (LIDS). A total of 524 997 women fit these
initial inclusion criteria.
To ensure that we captured Pap tests performed for
screening and not diagnostic purposes, we excluded
women with an available history of gynaecological can-
cer in Ontario Cancer Registry records (1 427 women),
or colposcopy in physicians’ claims records (42 704
women). Women who have had a total hysterectomy are
no longer screening-eligible, therefore we also excluded
26 598 women with an available history of such in hos-
pital discharge records. Ontario has newly instituted pri-
mary care patient enrolment models (PEMs), which
include financial incentives for family physicians to per-
form cervical cancer screening on enrolled women aged
35-69 years. Because the tracking code Q140A can be
claimed by Ontario physicians who participate in these
models for any enrolled female patient aged 35-69 years
who is ineligible for cervical cancer screening for any
reason, we excluded 6 008 women who had a Q140A
code claimed at least once in available records. Due to
o v e r l a po fr e a s o n sf o re x c l u s i o n ,at o t a lo f6 91 3 3
women were excluded. Therefore, the final cohort con-
sisted of 455 864 women.
Stratified Multivariate Analysis
To classify women by region of origin, we accessed
LIDS to determine country of birth for each woman.
The countries were then grouped into regions based on
a modification of the classification system used by the
World Bank[29]. To determine if region of origin acted
as an effect modifier, we conducted a stratified multi-
variate analysis by creating eight identical models, strati-
fied by the eight world regions.
As our outcome is relatively common, odds ratios
determined from logistic regression would not provide
an accurate estimate of relative risks. Therefore, we
used multivariate Poisson regression[30] to estimate
adjusted relative risks. Models included variables in
three categories: sociodemographic, health care-related
and migration-related variables that may influence the
likelihood of cervical cancer screening. For sociodemo-
graphic variables, we considered:
￿ age category (18-34 years, 35-49 years [referent], 50-
66 years) as there are financial incentives in PEMs for
screening women 35 years and over and as women 50
years and over have previously been found to be under-
screened[6,8,31]
￿ neighbourhood income quintile
￿ whether each woman lived in a small urban versus
large urban setting based on her Rurality Index of
Ontario score
￿ whether she had a university degree at the time of
landing in Ontario. Health care-related variables
included:
￿ whether each woman had at least one major prenatal
visit during the study period, as Pap tests are expected
aspects of these visit types and may be more acceptable
during these visits
￿ whether she had seen a gynaecologist at least once
during the study period
￿ whether she was rostered in a PEM
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physician regularly who participates in a PEM despite
the woman not being enrolled herself
￿ whether the woman had at least one female provider
(either family physician or gynaecologist)
￿ whether she had at least one provider from the same
region of the world (either family physician or gynaecol-
ogist) based on the physician’s medical school
￿ the presence of co-morbidities in the two years prior
to the index date based on the Johns Hopkins Adjusted
Clinical Groups Case-Mix System, which. uses diagnos-
tic information from administrative databases to
describe and predict patients’ use of health care
resources. In this study, we used Resource Utilization
Bands, which range from 0 (lowest expected health care
costs) to 5 (highest expected health care costs), to cate-
gorize patients based on their expected use of health
care resources, and Aggregated Diagnosis Groups, which
range from 0 (no diagnosis group) to 32 (a maximum of
32 distinct diagnosis groups) to categorize the level of
co-morbidity. This system has been validated for use in
Canadian populations[32].
Migration-related variables included:
￿ immigrant class (economic [referent], family,
refugee)
￿ English speaking ability at landing
￿ whether she had been in Canada less than 10 years
￿ age at landing.
SAS Version 9.1 (SAS Institute Inc, Cary, NC) was
used to fit all models and determine adjusted relative
risks.
Adjusted relative risks (ARR s )w e r et h e nu s e dt oc a l -
culate population-attributable fractions (PAFs) for each
variable using the following formula:
PAF = p (ARR − 1)/(1+p(ARR − 1))
where p was the proportion of the study population
with the variable of interest.
Outcome Definition
To determine if each woman in the cohort had been
appropriately screened for cervical cancer, we used a
previously validated billing code-based algorithm con-
sisting of all procedural codes that can be billed by
the physician performing the Pap test and all labora-
tory codes that can be billed by the cytopathologist
interpreting the Pap test. A woman was considered
appropriately screened if at least one of the specified
billing codes had been claimed for her in the three-
year study period. This algorithm had 99.5% sensitiv-
ity and 85.7% specificity when compared to a Pap test
registry [6].
Results
Characteristics of the study population are summarized
in Table 1. The largest immigrant groups were from
East Asia and the Pacific (128 965 women) and from
South Asia (88 107 women). The smallest group was
from the USA, Australia and New Zealand (10 003
women). Women from Latin America and the Carib-
bean and from Sub-Saharan Africa were most likely to
be living in the poorest neighbourhoods, and least likely
to have a university degree. There was a mismatch
between university-level education and income for
South Asian women, with a high representation in low-
income neighbourhoods but a high level of educational
attainment. Women from the USA, Australia and New
Zealand had the highest educational attainment, and
had the least amount of health care contact. South
Asian women were the most likely to have at least one
female provider and to have a provider from the same
region of the world, and were most commonly rostered
in PEMs. Eastern European and Central Asian women
were the least likely to be able to speak English at land-
ing, and women from Sub-Saharan Africa were the most
likely to arrive as refugees.
A total of 213 729 women (46.9%) were not screened
for cervical cancer during the three-year study period.
Table 2 displays numbers and percentages of women
who were not recently screened by region of origin for
particular variables of interest. Women who had at least
o n ef e m a l ep r o v i d e rw e r et h el e a s tl i k e l yt ob e
unscreened, with the lowest number of unscreened
women seen among Caribbean and Latin American
women who had at least one female provider (21.2%).
The highest proportions of unscreened women were
seen among those women who were neither in a PEM
nor virtually rostered, with percentages consistently
above 90%. Among those women who were neither in a
PEM nor virtually rostered, only 11.8% had any contact
at all with the health care system during the study per-
iod (i.e. a physician office visit, hospitalization, emer-
gency room visit, laboratory test, imaging procedure, or
drug benefit claim). Of these women who had health
care contact, 70.1% were still not recentlyly screened,
ranging from 61.1% for women from the USA, Australia
and New Zealand to 77.4% for Middle East and North
African women (data not shown).
In our eight stratified models, there was little effect
modification by region (Table 3). Certain variables were
significantly associated with lack of screening across all
or nearly all world regions. These consisted of being in
either the youngest or oldest age groups and in the low-
est income quintiles among the sociodemographic vari-
ables; and not being in a patient enrolment model,
having a provider from the same region, and not having
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Page 3 of 11Table 1 Demographic characteristics of the 455 864 identified immigrant women in the cohort who were aged 18-66
on January 1, 2006 by region of origin
East
Asia
&Pacific
Eastern
Europe &
Central Asia
Latin
America &
Caribbean
Middle East
& North
Africa
South
Asia
Sub-
Saharan
Africa
USA, Australia
& New
Zealand
Western
Europe
All
identified
Immigrants
n 128 965 67 845 70 184 33 649 88 107 26 125 10 003 30 167 455 864
SOCIODEMOGRAPHIC FACTORS
Mean age (SD) 40.6
(11.3)
39.5 (11.8) 38.8 (11.8) 37.2 (12.1) 38.6
(11.8)
37.1
(10.9)
39.7 (11.8) 38.7
(11.5)
39.2 (11.7)
Age category, No. (%):
18-34 years 37 321
(28.9)
22 413 (33.0) 25 852 (36.8) 14 333 (42.6) 35 565
(40.4)
10 428
(39.9)
3 043 (30.4) 10 382
(34.4)
159 581
(35.0)
35-49 years 63 857
(49.5)
3 137 (45.9) 30 936 (44.1) 13 743 (40.8) 35 904
(40.8)
12 377
(47.4)
4 903 (49.0) 14 596
(48.4)
207 836
(45.6)
50-66 years 27 787
(21.6)
14 295 (21.1) 13 396 (19.1) 5 573 (16.6) 16 638
(18.9)
3 320
(12.7)
2 057 (20.6) 5 189
(17.2)
88 447 (19.4)
Income Quintile, No. (%)
Q1 (lowest) 31 755
(24.6)
17 591 (25.9) 25 352 (36.1) 9 045 (26.9) 27 878
(31.6)
11 908
(45.6)
1 439 (14.4) 5 730
(19.0)
130 867
(28.7)
Q2 32 387
(25.1)
13 136 (19.4) 17 696 (25.2) 6 402 (19.0) 23 281
(26.4)
5 042
(19.3)
1 591 (15.9) 6 788
(22.5)
106 489
(23.4)
Q3 25 862
(20.1)
13 403 (19.8) 13 668 (19.5) 6 511 (19.4) 19 038
(21.6)
3 629
(13.9)
1 692 (16.9) 5 807
(19.3)
89 798 (19.7)
Q4 22 197
(17.2)
14 215 (21.0) 8 518 (12.1) 6 537 (19.4) 11 853
(13.5)
2 985
(11.4)
1 948 (19.5) 5 800
(19.2)
74 218 (16.3)
Q5 (highest) 16 556
(12.8)
9 434 (13.9) 4 841 (6.9) 5 105 (15.2) 5 964
(6.8)
2 478
(9.5)
3 311 (33.1) 5 997
(19.9)
53 815 (11.8)
No. (%) with
university degree*
28 369
(22.0)
16 729 (24.7) 4 029 (5.7) 6 832 (20.3) 21 923
(24.9)
2 317
(8.9)
3 390 (33.9) 2 740
(9.1)
86 525 (19.0)
No. (%) living in large
urban area
124 405
(96.5)
62 988 (92.9) 66 975 (95.5) 31 971 (95.1) 85 190
(96.7)
25 221
(96.6)
8 127 (81.4) 26 142
(86.7)
431 805
(94.8)
HEALTH CARE-RELATED FACTORS
No. (%) in RUB category:
0-1 34 440
(26.7)
13 368 (19.7) 10 967 (15.6) 8 170 (24.3) 13 835
(15.7)
5 591
(21.4)
4 592 (45.9) 10 138
(33.6)
101 345
(22.2)
2 19 351
(15.0)
10 843 (16.0) 8 439 (12.0 3 946 (11.7) 10 419
(11.8)
3 048
(11.7)
1 210 (12.1) 3 989
(13.2)
61 365 (13.5)
3 57 936
(44.9)
33 743 (49.7) 36 782 (52.4) 15 170 (45.1) 44 120
(50.1)
11 791
(45.1)
3 154 (31.5) 12 118
(40.2)
215 149
(47.2)
4-5 17 238
(13.4)
9 891 (14.6) 13 996 (19.9) 6 363 (18.9) 19 733
(22.4)
5 695
(21.8)
1 047 (10.5) 3 922
(13.0)
78 005 (17.1)
No. (%) in ADG category:
0-5 83 780
(65.0)
42 490 (62.6) 37 137 (52.9) 19 009 (56.5) 44 845
(50.9)
14 426
(55.2)
21 046 (69.8) 21 046
(69.8)
270 893
(59.4)
6-9 35 926
(27.9)
20 473 (30.2) 24 909 (35.5) 10 527 (31.3) 32 035
(36.4)
8 542
(32.7)
7 300 (24.2) 7 300
(24.2)
141 848
(31.1)
10+ 9 259
(7.2)
4 882 (7.2) 8 138 (11.6) 4 113 (12.2) 11 227
(12.7)
3 157
(12.1)
1 821 (6.0) 1 821
(6.0)
43 123 (9.5)
No. (%) with prenatal
visit during study
period
5 736
(4.5)
3 579 (5.3) 4 610 (6.6) 1 905 (5.7) 7 312
(8.3)
2 000
(7.7)
321 (3.2) 1 507
(5.0)
26 995 (5.9)
No. (%) in: Patient
enrolment model
80 584
(62.5)
41 953 (61.8) 47 620 (67.9) 21 227 (63.1) 63 195
(71.7)
16 682
(63.9)
5 101 (51.0) 17 707
(58.7)
294 553
(64.6)
Virtually rostered 23 706
(18.4)
17 131 (25.3) 14 979 (21.3) 6 302 (18.7) 15 499
(17.6)
5 374
(20.6)
1 123 (11.2) 4 482
(14.9)
88 732 (19.5)
Neither 24 675
(19.1)
8 761 (12.9) 7 585 (10.8) 6 120 (18.2) 9 413
(10.7)
4 069
(15.6)
3 779 (37.8) 7 978
(26.5)
72 579 (15.9)
No. (%) with female
provider
45 676
(35.4)
28 917 (42.6) 23 234 (33.1) 12 555 (37.3) 42 068
(47.8)
9 679
(37.1)
3 188 (31.9) 10 866
(36.0)
176 471
(38.7)
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ables. None of the migration-related variables were con-
sistently significantly associated with lack of screening.
Being unable to speak English at landing trended toward
increased risk for most women, but equated to signifi-
cantly decreased risk for East Asian and Pacific women.
Immigrant class was only significant for Sub-Saharan
African women and Western European women, with
refugees being at higher risk of non-screening in these
two groups. Post-hoc, we tested for an interaction
between female provider and provider from the same
region of the world, but it was not pervasively statisti-
cally significant so we did not include this interaction in
the models.
We then determined PAFs for these variables (data
not shown). For all women, the highest PAFs were seen
f o rn o th a v i n gaf e m a l ep r o v i d e r ,w i t hv a l u e sr a n g i n g
from 16.8% [95% CI 14.6-19.1%] among women from
t h eM i d d l eE a s ta n dN o r t hA f r i c at o2 7 . 4 %[ 9 5 %C I
26.2-28.6%] for women from East Asia and the Pacific.
The next highest PAFs varied by region of origin. Risk
of non-screening could be attributed to being in the
youngest age group for Latin American and Caribbean
women (7.4% [95% CI 5.7-9.1%]), Middle Eastern and
North African women (7.5% [95% CI 5.1-9.9%]), and
South Asian women (7.7% [95% CI 6.4-9.1%]). Being
neither rostered nor virtually rostered in a primary care
model was of especial importance for women from East
Asia and the Pacific (5.9% [95% CI 5.3-6.5%]), the USA,
Australia and New Zealand (9.5% [95% CI 6.2-12.8%]),
and Western Europe (12.1% [95% CI 10.4-13.8%]), as
was not having a university degree for Eastern European
and Central Asian women (6.9% [95% CI 4.7-9.1%]), and
being in the lowest income quintile for Sub-Saharan
African women (8.9% [95% CI 5.7-12.1%]).
Discussion
The cervical cancer screening rate of 53.1% that we
have demonstrated for a three-year period for Ontar-
io’s immigrant women living in urban areas, all of
whom were eligible for the provincial universal health
care system, is substantially lower than would be
expected with adherence to provincial guidelines[5],
and substantially lower than the 64.6% we have pre-
viously found for long-term residents of Ontario living
in urban areas during the same time period[14]. Socio-
demographic and health care-related factors, namely
living in the lowest-income neighbourhoods, not being
in the 35-49 year age group, not being either rostered
or virtually rostered in a patient enrolment model, and
having either a male family doctor or a family doctor
from the same region of the world were independently
associated with lower rates of screening for immigrant
women across most or all regions of origin, suggesting
that these variables tend to negatively affect screening
for immigrant women regardless of their culture or
ethnicity. Even when limiting to women with at least
one contact with the health care system during the
study period, the prevalence of non-screening was still
quite high for women without a family doctor,
Table 1 Demographic characteristics of the 455 864 identified immigrant women in the cohort who were aged 18-66
on January 1, 2006 by region of origin (Continued)
No. (%) with provider
from same region
28 081
(21.8)
19 713 (29.1) 5 397 (7.7) 8 380 (24.9) 34 374
(39.0)
1 937
(7.4)
58 (0.6) 2 911
(9.7)
100 851
(22.1)
No. (%) with
gynaecologist
27 739
(21.5)
20 547 (30.3) 22 028 (31.4) 8 822 (26.2) 23 768
(27.0)
7 557
(28.9)
1 472 (14.7) 5 985
(19.8)
118 075
(25.9)
MIGRATION-RELATED FACTORS
No. (%) able to speak
English*
73 105
(56.7)
24 623 (36.3) 57 012 (81.2) 17 673 (52.5) 43 638
(49.5)
18 700
(71.6)
9 675 (96.7) 19 901
(66.0)
264 848
(58.1)
No. (%) in Canada less
than 10 yrs
18 931
(14.7)
10 919 (16.1) 6 184 (8.8) 5 578 (16.6) 20 179
(22.9)
3 700
(14.2)
1 094 (10.9) 1 908
(6.3)
68 827 (15.1)
Mean age at landing
(SD)
28.8
(11.5)
27.8 (12.0) 25.5 (12.0) 25.8 (12.4) 28.1
(11.9)
25.2
(11.0)
26.3 (12.1) 24.2
(11.9)
27.2 (11.9)
Immigrant class, No. (%)
Economic 74 615
(57.9)
26 577 (39.2) 21 684 (30.9) 16 956 (50.4) 30 904
(35.1)
7 669
(29.4)
3 508 (35.1) 19 438
(64.4)
201 872
(44.3)
Family 47 632
(36.7)
21 099 (31.1) 41 312 (58.9) 8 688 (25.8) 43 243
(49.1)
8 450
(32.3)
6 255 (62.5) 9 783
(32.4)
186 444
(40.9)
Refugee 5 817
(4.5)
19 621 (28.9) 7 010 (10.0) 7 836 (23.3) 13 278
(15.1)
9 834
(37.6)
238 (2.4) 940 (3.1) 64 618 (14.2)
*Recorded on date of landing in Canada
RUB = Resource Utilization Bands, which range from 0 (lowest expected health care costs) to 5 (highest expected health care costs), used to categorize patients
based on their expected use of health care resources.
ADG = Aggregated Diagnosis Groups, which range from 0 (no diagnosis group) to 32 (32 distinct diagnosis groups) used to measure the level of co-morbidity.
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Page 5 of 11Table 2 Number (and percentage) of women without a Pap test in 2006-8 among the 455 864 identified immigrant
women in the cohort who were aged 18-66 on January 1, 2006 by region of origin
East Asia
& Pacific
Eastern
Europe &
Central Asia
Latin
America &
Caribbean
Middle East
& North
Africa
South
Asia
Sub-
Saharan
Africa
USA, Australia
& New
Zealand
Western
Europe
All
identified
immigrants
SOCIODEMOGRAPHIC FA CTORS
Age category:
18-34 years 19 513
(52.3)
8 640 (38.6) 9 305 (36.0) 8 082 (56.4) 17 828
(50.1)
5 443
(52.2)
1 913 (62.9) 4 991
(48.1)
75 863 (47.5)
35-49 years 28 916
(45.3)
12 327 (39.6)’ 10 214 (33.0) 6 358 (46.3) 15 689
(43.7)
5 643
(45.6)
2 670(54.5) 7 009
(48.0)
89 019 (42.8)
50-66 years 15 053
(54.2)
7 456 (52.2 6 412 (47.9) 3 146 (56.5) 10 503
(63.1)
1 768
(53.3)
1 344 (65.3) 3 057
(58.9)
48 847 (55.2)
Income Quintile
Q1 (lowest) 16 980
(53.5)
9 102 (51.7) 10 078 (39.8) 5 375 (59.4) 15 358
(55.1)
6 494
(54.5)
976 (67.8) 3 330
(58.1)
67 778 (51.8)
Q2 15 677
(48.4)
5 827 (44.4) 6 612 (37.4) 3 472 (54.2) 11 534
(49.5)
2 405
(47.7)
985 (61.9) 3 522
(51.9)
50 126 (47.1
Q3 11 974
(46.3)
5 078 (37.9) 4 519 (33.1) 3 103 (47.7) 8 794
(46.2)
1 658
(45.7)
972 (57.5) 2 750
(47.4)
38 957 (43.4)
Q4 10 279
(46.3)
4 933 (34.7) 2 839 (33.3) 3 112 (47.6) 5 445
(45.9)
1 225
(41.0)
1063 (54.6) 2 580
(44.5)
31 565 (42.5)
Q5 (highest) 8 443
(51.0)
3 441 (36.5) 1 832 (37.8) 2 492 (48.8) 2 838
(47.6)
1 017
(41.0)
1 913 (57.8) 2 845
(47.4)
24 893 (46.3)
University degree:
Yes 14 141
(49.9)
6 605 (39.5) 1 661 (41.2) 3 495 (51.2) 10 426
(45.1)
1 046
(45.1)
1 815 (53.5) 1 349
(49.2)
40 665 (47.0)
No 49 341
(49.1)
21 818 (42.7) 24 270 (36.7) 14 091 (52.6) 33 594
(50.8)
11 808
(49.6)
4 112 (62.2) 13 708
(50.0)
173 064
(46.9)
HEALTH CARE-RELATED FACTORS
Patient enrolment
model
29 196
(36.2)
13 403 (32.0) 13 366 (28.1) 8 545 (40.3) 27 200
(43.0)
6 358
(38.1)
1 770 (34.7) 5 512
(31.1)
105 538
(35.8)
Virtually rostered 10 262
(43.3)
6 803 (39.7) 5 465 (36.5) 3 072 (48.8) 7 707
(49.7)
2 594
(48.3)
450 (40.1) 1 760
(39.3)
38 177 (43.0)
Neither 24 024
(97.4)
8 217 (93.8) 7 100 (93.6) 5 969 (97.5) 9 113
(96.8)
3 902
(95.9)
3 707 (98.1) 7 785
(97.6)
70 014 (96.5)
Female provider:
Yes 11 434
(25.0)
7 359 (25.5) 4 924 (21.2) 3 971 (31.6) 13 947
(33.2)
2 961
(30.6)
873 (27.4) 2 653
(24.4)
48 220 (27.3)
No 52 048
(62.5)
21 064 (54.1) 21 007 (44.7) 13 615 (64.5) 30 073
(65.3)
9 893
(60.2)
5 054 (74.2) 12 404
(64.3)
165 509
(59.2)
region:
Yes 11 279
(40.2)
6 474 (32.8) 1 546 (28.7) 3 653 (43.6) 14 760
(42.9)
614 (31.7) 19 (32.8) 992 (34.1) 39 337 (39.0)
No 52 203
(51.8)
21 949 (45.6) 24 385 (37.6) 13 933 (55.1) 29 260
(54.5)
12 240
(50.6)
5 908 (59.4) 14 065
(51.6)
174 392
(49.1)
MIGRATION-RELATED F ACTORS
Able to speak English:
Yes 36 886
(50.5)
10 012 (40.7) 20 479 (35.9) 9 165 (51.9) 21 656
(49.6)
8 974
(48.0)
5 718 (59.1) 9 867
(49.6)
123 036
(46.5)
No 26 596
(47.6)
18 411 (42.6) 5 452 (41.4) 8 421 (52.7) 22 364
(50.3)
3 880
(52.3)
209 (63.7) 5 190
(50.6)
90 693 (47.5)
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Page 6 of 11suggesting that complete lack of health care system
contact did not explain this finding.
Our findings are similar to those of other studies that
have shown that the gender and cultural origin of the
family physician, and income and age of the patient,
matter for cervical cancer screening. In another Cana-
dian study, Decker et al. demonstrated that Canadian
medical graduates and female physicians were more
likely than international medical graduates and male
physicians respectively to perform Pap tests[33]. In their
literature review, Akers et al. noted that female doctors
were consistently more likely to perform cervical screen-
ing and that having a doctor of the same ethnicity was
associated with lower rates of screening[34]. Tu et al.
showed that female physicians were more likely to
screen for breast and cervical cancer among Chinese
immigrants in both Seattle, USA and Vancouver,
Canada[35], and in qualitative studies, immigrant
women consistently report that having a female perform
the Pap test would increase their comfort level[36-40].
Low-income women have frequently been highlighted as
vulnerable to under-screening, both among foreign-born
women and among the general population
[2,6-8,23,33,41,42]. Although many international studies
have shown that older age is associated with lower rates
of cervical cancer screening among both immigrants
and the general population[2,3,8,40,43-49], only a few
studies have highlighted women in the youngest age
group as vulnerable to under-screening and most of
these have focussed on women younger than 25 years
[23,49-51]. It must be noted that the benefits of screen-
ing for women under 25 years may be limited[52].
We also used PAFs to determine the screening bar-
riers of most importance for each cultural group, and
found that access to a female provider had the highest
attributable risk across regions of origin. Other
characteristics which decision makers could focus on
were also highlighted with some differences across
regions. These findings can be used for screening inter-
ventions that are targeted at particular ethnic groups.
For example, researchers and policymakers aiming to
increase screening among Sub-Saharan African women
may wish to focus their efforts on women living in the
poorest neighbourhoods.
Strengths and Limitations
This study has several strengths. It is a large, popula-
tion-based study with broad inclusion criteria that dis-
tinguishes immigrant women from all major geographic
regions of the world. It uses a previously validated out-
come measure[6] instead of self-report to document cer-
vical cancer screening. Self-report is known to
systematically overestimate screening attendance[53,54].,
It also relies on objective data instead of self-reported
data for immigration status and region of origin. The
effects of sociodemographics, health care-related factors
and migration-related factors on screening for immi-
grant women from all regions of the world were consid-
ered. As well, this is the only study that we are aware of
that has examined region of origin as a potential source
of effect modification and calculated region-specific
population-attributable fractions in order to determine
barriers to Pap test use of the most importance for each
cultural group.
This study also has several limitations. First, not all
potentially relevant information, such as religion, is
available from administrative data. Second, some data
were only available for women at the time of landing,
such as education attainment and language ability.
These may have changed for many women by the begin-
ning of the study period. Third, identified immigrants
were classified based on their country of birth, which
Table 2 Number (and percentage) of women without a Pap test in 2006-8 among the 455 864 identified immigrant
women in the cohort who were aged 18-66 on January 1, 2006 by region of origin (Continued)
In Canada:
less than 10 years 8 055
(42.6)
4 381 (40.1) 2 049 (33.1) 2 840 (50.9) 10 272
(50.9)
1 744
(47.1)
541 (49.5) 851 (44.6) 30 930 (44.9)
10+ years 55 427
(50.4)
24 042 (42.2) 23 882 (37.3) 14 746 (52.5) 33 748
(49.7)
11 110
(49.5)
5 386 (60.5) 14 206
(50.3)
182 799
(47.2)
Immigrant class:
Economic 39 334
(52.7)
10 684 (40.2) 8 599 (39.7)) 9 589 (56.6) 16 810
(54.4)
3 465
(45.2)
2 395 (68.3) 9 995
(51.4)
101 173
(50.1)
Family 21 369
(45.1)
9 060 (42.9) 14 442 (35.0) 4 150 (47.8) 20 514
(47.4)
3 821
(45.2)
3 396 (54.3) 4 584
(46.9)
81 461 (43.7)
Refugee 2 412
(41.5)
8 451(43.1) 2 822 (40.3) 3 761 (48.0) 6 357
(47.9)
5 499
(55.9)
135 (56.7) 475 (50.5) 29 932 (46.3)
TOTAL WITHOUT A
PAP TEST IN 2006-8
63 482
(49.2)
28 423 (41.9) 25 931 (36.9) 17 586 (52.3) 44 020
(50.0)
12 854
(49.2)
5 927 (59.2) 15 057
(49.9)
213 729
(46.9)
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Page 7 of 11Table 3 Adjusted relative risks [with 95% confidence intervals] for risk of non-screening for the 455 864 identified immigrant women in the cohort who were
aged 18-66 on January 1, 2006 by region of origin
East Asia &
Pacific
Eastern Europe &
Central Asia
Latin America &
Caribbean
Middle East &
North Africa
South Asia Sub-Saharan
Africa
USA, Australia &
New Zealand
Western
Europe
All identified
immigrants
SOCIODEMOGRAPHIC FACTORS
Age category:
18-34 years 1.20 [1.16-1.23] 1.16 [1.11-1.21] 1.22 [1.17-1.27] 1.19 [1.13-1.26] 1.21 [1.17-1.25] 1.16 [1.10-1.24] 1.13 [1.03-1.25] 1.19 [1.12-1.27] 1.24 [1.22-1.26]
35-49 years 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
50-66 years 1.20 [1.17-1.24] 1.08 [1.04-1.13] 1.24 [1.19-1.30] 1.16 [1.10-1.23] 1.30 [1.25-1.35] 1.09 [1.02-1.17] 1.06 [0.97-1.16] 1.10 [1.04-1.17] 1.15 [1.13-1.17]
Q1 (lowest) 1.10 [1.08-1.13] 1.15 [1.11-1.20] 1.10 [1.05-1.16] 1.14 [1.08-1.19] 1.12 [1.08-1.17] 1.21 [1.13-1.30] 1.09 [1.00-1.18] 1.12 [1.06-1.18] 1.14 [1.12-1.15]
Q2 1.03 [1.01-1.06] 1.09 [1.05-1.14] 1.06 [1.00-1.11] 1.09 [1.03-1.15] 1.07 [1.03-1.11] 1.12 [1.04-1.20] 1.06 [0.98-1.15] 1.09 [1.03-1.14] 1.07 [1.06-1.09]
Q3 1.01 [0.98-1.04] 1.03 [0.99-1.08] 0.97 [0.92-1.03] 1.01 [0.96-1.07] 1.02 [0.98-1.07] 1.12 [1.03-1.21] 1.03 [0.95-1.11] 1.06 [1.01-1.12] 1.03 [1.01-1.04]
Q4 0.99 [0.96-1.02] 1.00 [0.95-1.04] 0.97 [0.91-1.03] 1.01 [0.96-1.07] 1.00 [0.96-1.05] 1.01 [0.93-1.10] 0.99 [0.91-1.06] 1.00 [0.95-1.06] 1.0 [0.98-1.01]
Q5 (highest) 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
University degree:
No 0.98 [0.96-1.00] 1.10 [1.07-1.13] 1.05 [0.99-1.10] 1.01 [0.97-1.05] 1.06 [1.03-1.08] 1.03 [0.96-1.10] 1.06 [1.00-1.13] 1.04 [0.98-1.11] 1.01 [1.00-1.02]
Yes 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
HEALTH CARE-RELATED FACTORS
No family doctor 1.33 [1.30-1.36] 1.47 [1.41-1.52] 1.56 [1.49-1.62] 1.31 [1.24-1.37] 1.21 [1.17-1.26] 1.31 [1.24-1.39] 1.28 [1.17-1.39] 1.52 [1.44-1.60] 1.39 [1.37-1.41]
Virtually rostered 1.19 [1.16-1.21] 1.23 [1.19-1.27] 1.28 [1.24-1.32] 1.18 [1.13-1.23] 1.13 [1.10-1.16] 1.21 [1.15-1.26] 1.17 [1.05-1.29] 1.26 [1.20-1.33] 1.18 [1.17-1.20]
Patient enrolment
model
1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Female provider:
No 1.58 [1.55-1.62] 1.44 [1.40-1.49] 1.40 [1.35-1.45] 1.32 [1.27-1.38] 1.44 [1.41-1.47] 1.33 [1.27-1.39] 1.43 [1.31-1.55] 1.44 [1.38-1.52] 1.43 [1.41-1.45]
Yes 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Provider from
same region:
Yes 1.06 [1.04-1.09] 1.08 [1.05-1.12] 1.08 [1.02-1.13] 1.13 [1.08-1.17] 1.09 [1.07-1.11] 0.94 [0.86-1.02] 0.98 [0.62-1.53] 1.14 [1.07-1.22] 1.15 [1.13-1.16]
No 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
MIGRATION-RELATED FACTORS
Able to speak English
No 0.98 [0.96-0.99] 1.01 [0.98-1.04] 1.04 [1.01-1.08] 1.04 [1.00-1.07] 1.09 [1.06-1.11] 1.06 [1.02-1.10] 1.05 [0.90-1.22] 1.03 [1.00-1.07] 1.04 [1.03-1.05]
Yes 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
In Canada:
less than 10 years 1.00 [0.98-1.03] 1.01 [0.98-1.05] 0.97 [0.92-1.02] 1.06 [1.02-1.11] 1.09 [1.06-1.11] 1.05 [0.99-1.11] 1.10 [1.00-1.22] 1.05 [0.97-1.13] 1.05 [1.04-1.07]
10+ years 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Immigrant class:
Family 1.00 [0.99-1.02] 1.01 [0.98-1.04] 0.98 [0.95-1.01] 0.96 [0.93-1.00] 0.98 [0.95-1.00] 1.05 [1.00-1.10] 0.97 [0.91-1.02] 0.98 [0.95-1.02] 0.99 [0.98-1.00]
Refugee 0.96 [0.92-1.00] 1.00 [0.97-1.03] 1.03 [0.99-1.08] 1.00 [0.96-1.04] 1.02 [0.99-1.05] 1.20 [1.15-1.26] 1.07 [0.89-1.29] 1.08 [0.98-1.18] 1.06 [1.04-1.07]
Economic 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Relative risks adjusted for all variables listed in the table.
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1may not always reflect their ethnic and cultural origins.
For example, 238 women born in the U.S. were in the
refugee class, most likely reflective of women of other
ethnic origins whose families lived for a time in the U.S.
before settling in Canada. Fourth, although we excluded
women where there was any evidence of a hysterectomy
in available data, we could not identify out-of-province
hysterectomies, which may be relatively common among
the immigrant women in the cohort. However, we also
excluded women who had a Q140 code billed, which
allows physicians in primary care enrolment models to
flag those patients whom they have deemed ineligible
for screening. All identified immigrants had been in
Ontario for over five years by the first day of the study
period, and on average, had been in the province for
over 10 years, decreasing the likelihood of out-of-pro-
vince hysterectomies. Finally, our results may not be
generalizable to other settings, either inside or outside
Canada, as other settings may have different immigrant
demographic profiles.
Conclusions
Our findings suggest that several interventions may be
beneficial for improving cervical cancer screening rates
among immigrant women in Ontario. First, efforts need
to be made to ensure that immigrant women get con-
nected with the health care system after arrival and find
a regular source of primary care. Settlement agencies
m a yb ea b l et op l a yas u b s t a n t i a lr o l et o w a r dt h i sg o a l .
Moving from Ontario’s current system of opportunistic
screening to one of centrally organized screening with
periodic invitations may also be of benefit for increasing
screening rates. Although it is neither feasible nor desir-
able for every immigrant woman to see a female provi-
der, efforts should also be made to increase the
enrolment of immigrant women in primary care patient
enrolment models. Importantly, some primary care
models may also make it feasible for male physicians to
have female health professionals, such as trained nurses,
physician assistants or nurse practitioners, available to
provide cervical cancer screening, which may increase
immigrant women’s comfort with having the procedure
performed. As well, targeted physician education cam-
paigns for physicians trained abroad may be beneficial
for improving screening rates. Future work should
examine the reasons for lower screening rates when
there is ethnic congruence between a physician and
patient. Targeted patient education campaigns and
interventions for all immigrant women will likely also be
of utmost importance, with a particular focus on
younger and older women, and on women of low
income.
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